U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announced today that it has received a $4 million Technology & Therapeutic Development Award (TTDA) from the United States Department of Defense (DOD) through the Peer Reviewed Medical Research Program (PRMRP) of the Congressionally Directed Medical Research Programs (CDMRP). The contract will fund the first … Read more